Skip to main content
SpringerLink
Log in

Pathogenesis of Non-Hodgkin Lymphoma Derived from Inflammatory, Autoimmune or Immunologic Disorders

  • Chapter
  • First Online:
Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

Part of the book series: Cancer Growth and Progression ((CAGP,volume 14))

  • 1257 Accesses

Abstract

The risk of lymphoproliferative disorders has been reported to be increased in autoimmune rheumatic disease and chronic inflammatory diseases. The autoimmune rheumatic diseases, also called autoimmune disorders, that frequently are associated with lymphomas are namely rheumatoid arthritis, Sjörgen syndrome, systemic lupus erythematous, celiac disease, Crohn disease, and Hashimoto thyroiditis (Dias and Isenberg 2011; Tvarůzková et al. 2011; Maverakis et al. 2011; Mellemkjaer et al. 2008).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdul-Rahman ZH, Gogas HJ, Tooze JA, Anderson B, Mansi J, Sacks NP, Finlayson CJ (1996) T-cell lymphoma in Hashimoto’s thyroiditis. Histopathology 29(5):455–459

    Article  PubMed  CAS  Google Scholar 

  • Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188

    Article  PubMed  Google Scholar 

  • Anolik JH (2007) B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis 65(3):182–186

    PubMed  Google Scholar 

  • Arai H, Maki K, Tadokoro J, Nakamura Y, Sasaki K, Mitani K (2011) Extranodal NK/T-cell lymphoma, nasal type, developed in a patient with rheumatoid arthritis. Rinsho Ketsueki 52(7):551–555

    PubMed  Google Scholar 

  • Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS (2009) Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology (Oxford) 48(11):1451–1454

    Article  CAS  Google Scholar 

  • Ashworth LA, Billett A, Mitchell P, Nuti F, Siegel C, Bousvaros A (2012) Lymphoma risk in children and young adults with inflammatory bowel disease: analysis of a large single-center cohort. Inflamm Bowel Dis 18(5):838–843, Epub 2011 Sep 1

    Article  PubMed  Google Scholar 

  • Baimpa E, Dahabreh U, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjogren’s syndrome: clinical and pathophysiological aspects. Medicine 88:284–293

    Article  PubMed  Google Scholar 

  • Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C (2005) Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren’s syndrome. Arthritis Rheum 52(6):1773–1784

    Article  PubMed  CAS  Google Scholar 

  • Bernatsky S, Ramsey-Goldman R, Clarke AE (2009) Malignancy in systemic lupus erythematosus: what have we learned? Best Pract Res Clin Rheumatol 23(4):539–547

    Article  PubMed  Google Scholar 

  • Bleesing JJH, Johnson J, Zhang K (2011) Autoimmune lymphoproliferative syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds) GeneReviews [Internet]. University of Washington, Seattle, 1993-.2006 Sep 14 [updated 2011 Sep 08]

    Google Scholar 

  • Bombardieri M, Pitzalis C (2012) Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren’s syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis. Curr Pharm Biotechnol Jan 2. [Epub ahead of print]

    Google Scholar 

  • Brent GA, Larsen PR, Davies TF (2008) Hypothyroidism and thyroiditis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, chap 12

    Google Scholar 

  • Busch R, Hadjinicolaou AV, Hall FC (2012) Local activation and systemic dysregulation of T Lymphocytes in Sjögren’s Syndrome. Curr Pharm Biotechnol Jan 2. [Epub ahead of print]

    Google Scholar 

  • Büyükaşık O, Hasdemir AO, Yalçın E, Celep B, Sengül S, Yandakçı K, Tunç G, Küçükpınar T, Alkoy S, Cöl C (2011) The association between thyroid malignancy and chronic lymphocytic thyroiditis: should it alter the surgical approach? Endokrynol Pol 62(4):303–308

    PubMed  Google Scholar 

  • Carmona L, Cross M, Williams B, Lassere M, March L (2010) Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24(6):733–745

    Article  PubMed  Google Scholar 

  • Cassaday RD, Malik JT, Chang JE (2011) Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn’s disease: a case report and review of the literature. Clin Lymphoma Myeloma Leuk 11(3):289–292

    Article  PubMed  CAS  Google Scholar 

  • Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243–269

    Article  PubMed  CAS  Google Scholar 

  • Conde L, Bracci PM, Halperin E, Skibola CF (2011) A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases. Genomics 98(1):9–14

    PubMed  CAS  Google Scholar 

  • Cosnes J, Nion-Larmurier I (2011) Complications of celiac disease. Pathol Biol (Paris) May 26. [Epub ahead of print] [Article in French]

    Google Scholar 

  • Dantec CL, Varin MM, Brooks WH, Pers JO, Youinou P, Renaudineau Y (2012) Epigenetics and Sjögren’s syndrome. Curr Pharm Biotechnol Jan 2. [Epub ahead of print]

    Google Scholar 

  • Daridon C, Blassfeld D, Reiter K, Mei HE, Giesecke C, Goldenberg DM, Hansen A, Hostmann A, Frölich D, Dörner T (2010) Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus. Arthritis Res Ther 12(6):R204, Epub 2010 Nov 4

    Article  PubMed  CAS  Google Scholar 

  • Delaleu N, Immervoll H, Cornelius J, Jonsson R (2008) Biomarker profiles in serum and saliva of experimental Sjögren’s syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 10(1):R22

    Article  PubMed  CAS  Google Scholar 

  • Dias C, Isenberg DA (2011) Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma. Nat Rev Rheumatol 7(6):360–368

    Article  PubMed  CAS  Google Scholar 

  • Dommasch E, Gelfand JM (2009) Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther 22(5):418–430

    Article  PubMed  Google Scholar 

  • Dorner T, Kaufmann J, Wegener WA, Teoh N, Goldenberg DM, Burmester GR (2006) Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Ther 8(3):R74, Epub 2006 Apr 21

    Article  PubMed  CAS  Google Scholar 

  • Dreyer L, Faurschou M, Mogensen M, Jacobsen S (2011) High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum 63(10):3032–3037

    Article  PubMed  Google Scholar 

  • Ebringer A, Rashid T (2006) Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clin Dev Immunol 13(1):41–48

    Article  PubMed  CAS  Google Scholar 

  • Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111(8):4029–4038, Epub 2008 Feb 8

    Article  PubMed  CAS  Google Scholar 

  • Farcet J, Gaulard P, Marolleau J et al (1990) Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma-delta. Blood 75(11):2213–2219

    PubMed  CAS  Google Scholar 

  • Fox RI, Kang HI (1992) Pathogenesis of Sjögren’s syndrome. Rheum Dis Clin North Am 18(3):517–538

    PubMed  CAS  Google Scholar 

  • Fox RI, Stern M (2002) Sjögren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol 116(Suppl):3–13, Review

    Google Scholar 

  • Freeman HJ (2010) Hepatic manifestations of celiac disease. Clin Exp Gastroenterol 3:33–39

    Article  PubMed  Google Scholar 

  • Guerrier T, Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P (2012) Role of toll-like receptors in primary Sjögren’s syndrome with a special emphasis on B-cell maturation within exocrine tissues. J Autoimmun 39(1–2):69–76, Epub 2012 Feb 21

    Article  PubMed  CAS  Google Scholar 

  • Ha CS, Shadle KM, Medeiros LJ, Wilder RB, Hess MA, Cabanillas F, Cox JD (2001) Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 91:629–635

    Article  PubMed  CAS  Google Scholar 

  • Hansen A, Lipsky PE, Dörner T (2005) Immunopathogenesis of primary Sjögren’s syndrome: implications for disease management and therapy. Curr Opin Rheumatol 17(5):558–565

    Article  PubMed  CAS  Google Scholar 

  • Harris ED Jr, Firestein GS (2008) Clinical features of rheumatoid arthritis. In: Firestein GS, Budd RC, Harris ED Jr (eds) Kelley’s textbook of rheumatology, 8th edn. Saunders Elsevier, Philadelphia, chapter 66

    Google Scholar 

  • Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5):1361–1392

    PubMed  CAS  Google Scholar 

  • Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE (2011) Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol 106(12):2146–2153

    Article  PubMed  CAS  Google Scholar 

  • Holm LE, Blomgren H, Lowhagen T (1985) Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312(10):601–604

    Article  PubMed  CAS  Google Scholar 

  • Hsu AP, Dowdell KC, Davis J, Niemela JE, Anderson SM, Shaw PA, Rao VK, Puck JM (2012) Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance. Genet Med 14(1):81–89, Epub 2011 Oct 7

    Article  PubMed  CAS  Google Scholar 

  • Inaba M, Ushijim S, Hirata N, Saisyoji T, Kitaoka M, Yoshinaga T (2011) Methotrexate-related lymphomatoid granulomatosis in a patient with rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi 49(8):597–601 [Article in Japanese]

    PubMed  Google Scholar 

  • Isaacson PG, Chott A, Ott G, Stein H (2008a) Enteropathy-associated T-cell lymphoma. In: Swerdlow S (ed) WHO classification of tumors of hematopoietic and lymphoid tissue. IARC, 69008, Lyon, France pp 289–291

    Google Scholar 

  • Isaacson PG, Chott A, Nakamura S, Mueller-Hermelink HK, Harris NL, Swerdlow SH (2008b) Extradonal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH (ed) WHO classification of tumors of hematopoietic and lymphoid tissues. IARC, 69008, Lyon, France pp 214–219

    Google Scholar 

  • ISD Cancer Information Programme, Cancer statistics (2009) Non-Hodgkin’s lymphoma: ICD-10 C82-C85. http://www.isdscotland.org/isd/1483.html Cancer prevalence

  • Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 111(1 Suppl 1):S8–S12

    PubMed  CAS  Google Scholar 

  • Jarrassé C, Pagnier A, Edan C, Landman-Parker J, Mazingue F, Mansuy L, Bertrand Y, Paillard C, Pellier I, Margueritte G, Plantaz D (2011) Hodgkin disease and autoimmunity in children: 11 case reports. Arch Pediatr 18(4):376–382 [Article in French]

    Article  PubMed  Google Scholar 

  • Jones JL, Loftus EV Jr (2007) Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment? Inflamm Bowel Dis 13(10):1299–1307

    Article  PubMed  Google Scholar 

  • Jonsson R, Bowman SJ, Gordon TP (2005) Sjögren’s syndrome. Ch. 78. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions, 15th edn. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania, USA, pp 1681–1705

    Google Scholar 

  • Kallenberg CG, Vissink A, Kroese FG, Abdulahad WH, Bootsma H (2011) What have we learned from clinical trials in primary Sjögren’s syndrome about pathogenesis? Arthritis Res Ther 13(1):205

    Article  PubMed  CAS  Google Scholar 

  • Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko HJ, Ju JH, Cho CS, Kim HY, Park SH (2010) Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol 29(4):381–388

    Article  PubMed  Google Scholar 

  • Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 88:888–892

    Google Scholar 

  • Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T lymphocytes in Sjögren’s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 32(3):252–264

    Article  PubMed  CAS  Google Scholar 

  • Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol 175(3):1167–1177, Epub 2009 Aug 21

    Article  PubMed  CAS  Google Scholar 

  • Kavvoura FK, Akamizu T, Awata T et al (2007) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease; a meta-analysis. J Clin Endocrinol Metab 92(92):3162–3170

    Article  PubMed  CAS  Google Scholar 

  • Kim NR, Ko YH, Lee YD (2010) Primary T-cell lymphoma of the thyroid associated with Hashimoto’s thyroiditis, histologically mimicking MALT-lymphoma. J Korean Med Sci 25(3):481–484

    Article  PubMed  Google Scholar 

  • Kiss E, Kovacs L, Szodoray P (2010) Malignancies in systemic lupus erythematosus. Autoimmun Rev 9(4):195–199

    Article  PubMed  CAS  Google Scholar 

  • Koida S, Tsukasaki K, Tsuchiya T, Harasawa H, Fukushima T, Yamada Y, Ohshima K, Kamihira S, Kikuchi M, Tomonaga M (2007) Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica 92(3):e37–e40

    Article  PubMed  Google Scholar 

  • Krylova L, Isenberg D (2010) Assessment of patients with primary Sjögren’s syndrome--outcome over 10 years using the Sjögren’s Syndrome Damage Index. Rheumatology (Oxford) 49(8):1559–1562

    Article  Google Scholar 

  • Kwon JH, Farrell RJ (2005) The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol 56(1):169–178

    Article  PubMed  Google Scholar 

  • Le Guern V, Mouthon L (2011) Sjögren’s syndrome and non-Hodgkin’s lymphoma: from pathophysiology to treatment. Presse Med 40(12 Pt 1):1113–1119, Epub 2011 Oct 2. [Article in French]

    Article  PubMed  Google Scholar 

  • Li B, Tang Y, Xiao D, Zhong M (2010) Coexistence of thyroid metastasis carcinoma in the background of HT and primary thyroid mucosa-associated lymphoid tissue B cell lymphoma in a thyroid gland. Ann Hematol 89(10):1053–1056

    Article  PubMed  Google Scholar 

  • Löfström B, Backlin C, Pettersson T, Lundberg IE, Baecklund E (2011) Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 38(9):1891–1897

    Article  PubMed  Google Scholar 

  • Low JM, Moore TL (2005) A role for the complement system in rheumatoid arthritis. Curr Pharm Des 11:655–670

    Article  PubMed  CAS  Google Scholar 

  • Madkaikar M, Mhatre S, Gupta M, Ghosh K (2011) Advances in autoimmune lympho-proliferative syndromes. Eur J Haematol 87(1):1–9

    Article  PubMed  CAS  Google Scholar 

  • Mariette X (1999) Lymphomas in patients with Sjögren’s syndrome: review of the literature and physiopathologic hypothesis. Leuk Lymphoma 33(1–2):93–99

    PubMed  CAS  Google Scholar 

  • Maverakis E, Goodarzi H, Wehrli LN, Ono Y, Garcia MS (2012) The etiology of paraneoplastic autoimmunity. Clin Rev Allergy Immunol 42(2):135–144

    Article  CAS  Google Scholar 

  • Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O (2008) Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin’s lymphoma. Arthritis Rheum 58(3):657–666

    Article  PubMed  Google Scholar 

  • Moshynska OV, Saxena A (2008) Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol 61(4):438–444, Epub 2007 Nov 15

    Article  PubMed  CAS  Google Scholar 

  • Müschen M, Rajewsky K, Krönke M, Küppers R (2002) The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol 23(2):75–80

    Article  PubMed  Google Scholar 

  • Nakanishi H, Muta T, Oshiro Y, Hida A, Mizuno Y, Yasunaga M, Ueda Y, Fujisaki T (2011) B-cell lymphoma possessing t(14;18)(q32;q21)in a patient with rheumatoid arthritis receiving methotrexate treatment. Gan To Kagaku Ryoho 38(8):1365–1369

    PubMed  Google Scholar 

  • Nakazawa D (2008) The autoimmune epidemic. Simon & Schuster, New York, pp 32–35

    Google Scholar 

  • Nakou M, Bertsias G, Stagakis I, Centola M, Tassiulas I, Hatziapostolou M, Kritikos I, Goulielmos G, Boumpas DT, Iliopoulos D (2010) Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS One 5(10):e13351

    Article  PubMed  CAS  Google Scholar 

  • Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, Lanzarotti N, Stolzenberg MC, Bader-Meunier B, Aladjidi N, Chantrain C, Bertrand Y, Jeziorski E, Leverger G, Michel G, Suarez F, Oksenhendler E, Hermine O, Blanche S, Picard C, Fischer A, Rieux-Laucat F (2011) A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 118(18):4798–4807, Epub 2011 Sep 1

    Article  PubMed  CAS  Google Scholar 

  • Oehm A, Behrmann I, Falk W et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J Biol Chem 267(15):10709–10715

    PubMed  CAS  Google Scholar 

  • Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK (2010) Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116(14):e35–e40, Epub 2010 Jun 10

    Article  PubMed  CAS  Google Scholar 

  • Panayiotides IG, Foukas PG, Meristoudis C, Zourla AP, Peros G, Karakitsos P (2010) Simultaneous occurrence of Warthin-like papillary carcinoma and lymphoma of the mucosa associated lymphoid tissue in Hashimoto thyroiditis. J Clin Pathol 63(7):662–663

    Article  PubMed  Google Scholar 

  • Pasieka JL (1998) Anaplastic cancer, lymphoma, and metastases of the thyroid gland. Surg Oncol Clin N Am 7(4):707–720

    PubMed  CAS  Google Scholar 

  • Perfetti V, Brunetti L, Biagi F, Ciccocioppo R, Bianchi PI, Corazza GR (2012) TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease. J Clin Gastroenterol Jan 30. [Epub ahead of print]

    Google Scholar 

  • Perosa F, Favoino E, CaragnanoMA Prete M, Dammacco F (2005) A target antigen for immunotherapy of autoimmune diseases. Autoimmu Rev 4:526–531

    Article  CAS  Google Scholar 

  • Poppema S, Maggio E, van den Berg A (2004) Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma 45(3):423–431

    Article  PubMed  CAS  Google Scholar 

  • Prasad KK, Debi U, Sinha SK, Nain CK, Singh K (2011) Hepatobiliary disorders in celiac disease: an update. Int J Hepatol 2011:438184, Epub 2010 Nov 14

    PubMed  Google Scholar 

  • Ramos-Casals M, la Civita L, de Vita S, Solans R, Luppi M, Medina F, Caramaschi P, Fadda P, de Marchi G, Lopez-Guillermo A, Font J (2007) SS-HCV study group. Characterization of B cell lymphoma in patients with Sjögren’s syndrome and hepatitis C virus infection. Arthritis Rheum 57(1):161–170

    Article  PubMed  Google Scholar 

  • Rantapaa-Dahlqvist S (2005) Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 34:83–96

    Article  PubMed  CAS  Google Scholar 

  • Rao VK, Oliveira JB (2011) How I treat autoimmune lymphoproliferative syndrome. Blood 118(22):5741–5751

    Article  PubMed  CAS  Google Scholar 

  • Rosenblum H, Amital H (2011) Anti-TNF therapy: safety aspects of taking the risk. Autoimmun Rev 10(9):563–568, Epub 2011 May 5

    Article  PubMed  Google Scholar 

  • Rossi E, Catania G, Truini M, Ravetti GL, Grassia L, Marmont AM (2011) Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE. Clin Exp Rheumatol 29(3):555–559, Epub 2011 Jun 30

    PubMed  CAS  Google Scholar 

  • Ruggiero FP, Frauenhoffer E, Stack BC Jr (2005) Thyroid lymphoma: a single institution’s experience. Otolaryngol Head Neck Surg 133:888–896

    Article  PubMed  Google Scholar 

  • Salomonsson S, Larsson P, Tengnér P, Mellquist E, Hjelmström P, Wahren-Herlenius M (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren’s syndrome. Scand J Immunol 55(4):336–342

    Article  PubMed  CAS  Google Scholar 

  • Sharaiha RZ, Lebwohl B, Reimers L, Bhagat G, Green PH, Neugut AI (2012) Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973–2008. Cancer 118(15):3786–3792, Epub 2011 Dec 13

    Google Scholar 

  • Skopouli FN, Urania D, Ioannidis JPA (2000) Clinical evolution and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum 29:296–304

    Article  PubMed  CAS  Google Scholar 

  • Smedby KE, Baecklund E, Askling J (2006) Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 15(11):2069–2077

    Article  PubMed  CAS  Google Scholar 

  • Straus SE, Jaffe ES, Puck JM et al (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98(1):194–200

    Article  PubMed  CAS  Google Scholar 

  • Sugai S, Tachibana J, Sawada M, Shimizu S, Hirose Y, Takiguchi T, Konda S (1987) Malignant lymphomas in patients with autoimmune diseases: a report of 6 cases and a review of the Japanese literature. Jpn J Med 26(3):339–347

    Article  PubMed  CAS  Google Scholar 

  • Sultan K, Korelitz BI, Present D, Katz S, Sunday S, Shapira I (2012) Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease. Inflamm Bowel Dis Jan 12. [Epub ahead of print]

    Google Scholar 

  • Suvajdzic N, Djurdjevic P, Todorovic M, Perunicic M, Stojanović R, Novkovic A, Mihaljevic B (2011) Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases. Med Oncol Jul 14. [Epub ahead of print]

    Google Scholar 

  • Theander E, Andersson SI, Manthorpe R, Jacobsson LH (2005) Proposed core set of outcome measures in patients with primary Sjögren’s syndrome: 5 year follow-up. Rheumatology 32:109–116

    Google Scholar 

  • Tiemann M, Asbeck R, Wacker HH (1996) Clonal B-cell reaction in Sjögren disease and Hashimoto autoimmune thyroiditis. Pathologe 17(4):289–295 [Article in German]

    Article  PubMed  CAS  Google Scholar 

  • Toussirot E, Roudier J (2007) Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update. Joint Bone Spine 74(5):418–426

    Article  PubMed  CAS  Google Scholar 

  • Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 22(5):883–896

    Article  PubMed  CAS  Google Scholar 

  • Troch M, Woehrer S, Streubel B, Weissel M, Hoffmann M, Müllauer L, Chott A, Raderer M (2008) Chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) in patients with MALT lymphoma. Ann Oncol 19(7):1336–1339, Epub 2008 Mar 11

    Article  PubMed  CAS  Google Scholar 

  • Tvarůzková Z, Pavlová S, Doubek M, Mayer J, Pospísilová S (2011) Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes. Cas Lek Cesk 150(3):161–168 [Article in Czech]

    PubMed  Google Scholar 

  • Tzioufas AG, Voulgarelis M (2007) Update on Sjögren’s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21(6):989–1010

    Article  PubMed  CAS  Google Scholar 

  • Tzioufas AG, Kapsogeorgou EK, Moutsopoulos HM (2012) Pathogenesis of Sjögren’s syndrome: what we know and what we should learn. J Autoimmun 39(1–2):4–8, Epub 2012 Feb 10

    Article  PubMed  CAS  Google Scholar 

  • van de Schans SA, van Spronsen DJ, Hooijkaas H, Janssen-Heijnen ML, Coebergh JW (2011) Excess of autoimmune and chronic inflammatory disorders in patients with lymphoma compared with all cancer patients: a cancer registry-based analysis in the south of the Netherlands. Autoimmun Rev 10(4):228–234

    Article  PubMed  Google Scholar 

  • van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB (2002) Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol 236:48–53

    Article  Google Scholar 

  • Vanderpump MP, Tunbridge WM, French JM (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43(1):55–68

    Article  CAS  Google Scholar 

  • Vanderpump MP, French JM, Appleton D (1998) The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort. Clin Endocrinol (Oxf) 48(1):39–44

    Article  CAS  Google Scholar 

  • Varim MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO (2010) B-cell tolerance breakdown in Sjogren’s syndrome: focus on BAFF. Autoimmun Rev 9:604–608

    Article  CAS  Google Scholar 

  • Váróczy L, Páyer E, Kádár Z, Gergely L, Miltényi Z, Magyari F, Szodoray P, Illés A (2012) Malignant lymphomas and autoimmunity-a single center experience from Hungary. Clin Rheumatol 31(2):219–224, Epub 2011 Jul 7

    Article  PubMed  Google Scholar 

  • Vassilatou E, Economopoulos T, Tzanela M, Rontogianni D, Karakitsos P, Magou C, Hadjidakis D, Dimitriadis G (2011) Coexistence of differentiated thyroid carcinoma with primary thyroid lymphoma in a background of Hashimoto’s thyroiditis. J Clin Oncol 29(25):e709–e712

    Article  PubMed  Google Scholar 

  • Veeranki S, Choubey D (2010) Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins. Immunol Lett 133(1):1–5

    Article  PubMed  CAS  Google Scholar 

  • Vos AC, Bakkal N, Minnee RC, Casparie MK, de Jong DJ, Dijkstra G, Stokkers P, van Bodegraven AA, Pierik M, van der Woude CJ, Oldenburg B, Hommes DW, Initiative on Crohn’s and Colitis (ICC) (2011) Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflamm Bowel Dis 17(9):1837–1845, Epub 2010 Dec 22

    Article  PubMed  Google Scholar 

  • Voulgarelis M, Skopouli FN (2007) Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren’s syndrome patients. Clin Rev Allergy Immunol 32(3):265–274

    Article  PubMed  CAS  Google Scholar 

  • Voulgarelis M, Tzioufas AG (2010) Pathogenetic mechanisms in the initiation and perpetuation of Sjögren’s syndrome. Nat Rev Rheumatol 6(9):529–537

    Article  PubMed  CAS  Google Scholar 

  • Wang L, Zhao Y, Zhang FC (2010) Malignant lymphoma associated with primary Sjögren’s syndrome. Zhonghua Yi Xue Za Zhi 90(39):2773–2775 [Article in Chinese]

    PubMed  Google Scholar 

  • Watanabe N, Noh JY, Narimatsu H, Takeuchi K, Yamaguchi T, Kameyama K, Kobayashi K, Kami M, Kubo A, Kunii Y, Shimizu T, Mukasa K, Otsuka F, Miyara A, Minagawa A, Ito K (2011) Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto’s disease. Br J Haematol 153(2):236–243, Epub 2011 Mar 4

    Article  PubMed  Google Scholar 

  • Westhoff G, Zink A (2010) Epidemiology of primary Sjörgren’s syndrome. Z Rheumatol 69(1):41–49 [Article in German]

    Article  PubMed  CAS  Google Scholar 

  • Weyand CM, Seyler TM, Goronzy JJ (2005) B cells in rheumatoid synovitis. Arthritis Res Ther 7(suppl 3):S9–S12

    Article  PubMed  Google Scholar 

  • Whittingham S, McNeilage LJ, Mackay IR (1987) Epstein-Barr virus as an etiological agent in primary Sjögren’s syndrome. Med Hypotheses 22(4):373–386

    Article  PubMed  CAS  Google Scholar 

  • Wong AK, Kerkoutian S, Said J, Rashidi H, Pullarkat ST (2012) Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies. Clin Rheumatol 31(4):631–636, Epub 2011 Nov 18

    Article  PubMed  Google Scholar 

  • Ye BD (2011) Inflammatory bowel disease and lymphoproliferative disorders. Korean J Gastroenterol 58(4):171–177 [Article in Korean]

    Article  PubMed  Google Scholar 

  • Zuern C, Krenacs L, Starke S, Heimrich J, Palmetshofer A, Holtmann B, Sendtner M, Fischer T, Galle J, Wanner C, Seibold S (2012) Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease. Int J Oncol 40:1079–1088

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematopathology and Laboratory Medicine, Hematologic Malignancies, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA

    Ling Zhang M.D. & Jianguo Tao M.D., Ph.D.

Authors
  1. Ling Zhang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianguo Tao M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ling Zhang M.D. .

Editor information

Editors and Affiliations

  1. Research Institute, Department of Hematopathology and, H. Lee Moffitt Cancer Center &, Magnolia Drive - MCC-LAB 12902, Tampa, 33612, Florida, USA

    Jianguo Tao

  2. Research Institute, Department of Malignant Hematology, H. Lee Moffitt Cancer Center &, Magnolia Drive 12902, Tampa, 33612, Florida, USA

    Eduardo Sotomayor

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Zhang, L., Tao, J. (2012). Pathogenesis of Non-Hodgkin Lymphoma Derived from Inflammatory, Autoimmune or Immunologic Disorders. In: Tao, J., Sotomayor, E. (eds) Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Cancer Growth and Progression, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5028-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-5028-9_8

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-5027-2

  • Online ISBN: 978-94-007-5028-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation